Oxidation of low density lipoprotein in hemodialysis patients: Effect of dialysis and comparison with matched controls

Atherosclerosis

Volumn 129, Issue 2, 1997, Pages 199-205

  Westhuyzen, Justin ^a   Saltissi, David ^a   Healy, Helen ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

atherosclerosis; fatty acids; hemodialysis; lipid peroxidation; lipoproteins; low density lipoprotein; lysine

Indexed keywords

COPPER; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPID OXIDATION; MALE; PRIORITY JOURNAL;

AGED; ARTERIOSCLEROSIS; COPPER; FATTY ACIDS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KINETICS; LIPID PEROXIDATION; LIPIDS; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATION-REDUCTION; RENAL DIALYSIS;

EID: 0031002674     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06040-6     Document Type: Article

References (48)

1. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994;9:1136-1142.
2. Losowski MS, Kenward DH. Lipid metabolism in acute and chronic renal failure. J Lab Clin Med 1968;71:736-745.
3. Lowrie E, Lazarus M, Mocelin A, Bailey G, Hampers C, Wilson R, Merril J. Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med 1973;288:863-868.
4. Senti M, Romero R, Pedro-Botet J, Pelegri A, Nogues X, Rubies-Prat J. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Internat 1992;41:1394-1399.
5. Appel G. Lipid abnormalities in renal disease. Kidney Int 1991;39:169-183.
6. Attman P-O, Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int 1991;39(Suppl 31):516-523.
7. Webb AT, Reaveley DA, O'Donnell M, O'Connor B, Seed M, Brown EA. Lipids and lipoprotein (a) as risk factors for vascular disease in patients on renal replacement therapy. Nephrol Dial Transplant 1994;5:354-357.
8. Witztum JL. Susceptibility of low-density lipoprotein to oxidative modification. Am J Med 1993;94:347-349 (Editorial).
9. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
10. Witztum JL. Role of oxidised low density lipoprotein in atherogenesis. Br Heart J 1993;69(Suppl):12S-18S.
11. Aviram M. Oxidative modification of low density lipoprotein and its relation to atherosclerosis. Isr J Med Sci 1995;31:241-249.
12. Sies H. Oxidative stress: introductory remarks. In: Sies H (ed). Oxidative stress. London: Academic Press 1985:18.
13. Halliwell B. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. Am J Clin Nutr 1995;61(Suppl):670S-677S.
14. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in haemodialysis. Q J Med 1994;87:679-683.
15. Westhuyzen J, Adams CE, Fleming SJ. Evidence for oxidative stress during in vitro dialysis. Nephron 1995;70:49-54.
16. Miguel A, Miguel A, Linares M et al. Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients. Nephron 1988;50:64-65.
17. Schmidtmann S, V. Baehr R, Precht K. Free radicals induce increase lysis of red bloodcells after haemodialysis. Nephrol Dial Transplant 1990;5:600-603.
18. Richard MJ, Arnaud J, Jurkovitz C et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991;57:10-15.
19. Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992;41:1229-1232.
20. Kuroda M, Asaka S, Tofuku Y, Takeda R. Serum antioxidant activity in uraemic patients. Nephron 1985;41:293-298.
21. Ono K. Effects of large dose vitamin E supplementation on anaemia in haemodialysis patients. Nephron 1985;40:440-445.
22. Taccone-Gallucchi M, Giardini O, Lubrano R et al. Red blood cell peroxidation in predialysis renal failure. Clin Nephrol 1987;27:238-241.
23. Taccone-Gallucci M, Lubrano R, Bandino D et al. Discrepancies between serum and erythrocyte concentrations of vitamin E in hemodialysis patients: role of HDL-bound fraction of vitamin E. Artif Organs 1988;12:379-381.
24. Fillit H, Elion E, Sullivan J, Sherman R, Zabriskie JB. Thiobarbituric acid reactive material in uraemic blood. Nephron 1981;29:40-43.
25. Dasgupta A, Hussain S, Alunad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 1992;60:56-59.
26. Taylor JE, Scott N, Bridges A, Henderson IS, Stewart WK, Belch JJF. Lipid peroxidation in continuous ambulatory dialysis patients. Peritoneal Dial Int 1992;12:252-256.
27. Giardini O, Taccone-Gallucci M, Lubrano R et al. Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron 1984;36:235-237.
28. Loughrey CM, Young IS, McEneny J et al. Oxidation of low density lipoprotein in patients on regular haemodialysis. Atherosclerosis 1994; 110:185-193.
29. Maggi E, Bellazzi R, Falaschi F et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 1994;45:876-883.
30. Sutherland WHF, Walker RJ, Ball MJ, Stapley SA, Robertson MC. Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 1995;48:227-236.
31. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, McNamara JR, Ordovas JM. Lipoproteins, nutrition, aging, and atherosclerosis. Am J Clin Nutr 1995;61(Suppl):726S-740S.
32. Avram MM, Fein PA, Antignani A et al. Cholesterol and lipid disturbances in renal disease: the natural history of uraemic dyslipidaemia and the impact of haemodialysis and continuous ambulatory peritoneal dialysis. Am J Med 1989;87:55N-60N.
33. Sattler W, Bone P, Stocker R. Isolation of human VLDL, LDL, HDL and two subclasses in the TL-100 tabletop centrifuge using the TLA-100.4 rotor. Beckman Tech Inf 1992.
34. Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH, Demacker PNM. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem 1992;38:2066-2072.
35. Stembrecher UP, Witztum JL, Parthasarathy S, Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis 1987;7:135-143.
36. Liu K, Cuddy E, Pierce GN. Oxidative status of lipoproteins in coronary disease patients. Am Heart J 1992;123:285-290.
37. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-120.
38. Esterbauer H, Wäg G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993;49:566-576.
39. Sobenin IA, Tertov VV, Orekov AN, Smirnov VN. Synergistic effect of desialylated and glycated low density lipoproteins on cholesterol accumulation in cultured smooth muscle intimal cells. Atherosclerosis 1991;89:151-154.
40. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LFL. Free Radic Biol Med 1992;13:341-390.
41. Kleinveld HA, Naber AHJ, Stalenhoef AFH, DeMacher PNM. Oxidation resistance, oxidation rate and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Radical Biol Med 1993;15:273-280.
42. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoproteins to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993;91:668-676.
43. Abbey M, Belling GB, Noakes M, Hirata F, Nestel PJ. Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr 1993;57:391-398.
44. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol 1994;5:422-433.
45. Thomas CE, Jackson RL. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins. J Pharmacol Exp Ther 1991;256:1182-1188.
46. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 1991;88:1646-1650.
47. Sanderson KJ, Van Rij AM, Wade CR, Sutherland WHF. Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis 1995; 118:45-51.
48. Menasche P, Pasquier C, Bellucci S, Lorente P, Jaillon P, Piwnica A. Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1988;96:582-589.